HIGHLIGHTS
- who: Claudia M. Filozof and collaborators from the Institute of Pathology Medical University of Graz, Austria have published the research: Best Practices in Liver Biopsy Histologic Assessment for Nonalcoholic Steatohepatitis Clinical Trials: Expert Opinion, in the Journal: GastroHep of 19/07/2022
- what: The activity score (sum of ballooning and lobular inflammation scores) and stage can be used to define mild (A and amp;lt;3 and/or F and amp;lt;3) and substantial (A and/or F ≥2) severity of NAFLD with higher reported interobserver agreement and may be considered as an alternative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.